BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36055114)

  • 41. Neuropsychological profiles comparison between Multiple Sclerosis patients and Multiple Sclerosis patients with overlapping features of Systemic Lupus Erythematosus.
    Stavrogianni K; Kitsos DK; Giannopapas V; Chasiotis AK; Christouli N; Paraskevas PG; Zompola C; Tsivgoulis G; Paraskevas GP; Giannopoulos S
    J Neuroimmunol; 2024 Feb; 387():578270. PubMed ID: 38176314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidental learning during rapid information processing on the symbol-digit modalities test.
    Denney DR; Hughes AJ; Elliott JK; Roth AK; Lynch SG
    Arch Clin Neuropsychol; 2015 Jun; 30(4):322-8. PubMed ID: 25857404
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.
    Drake AS; Weinstock-Guttman B; Morrow SA; Hojnacki D; Munschauer FE; Benedict RH
    Mult Scler; 2010 Feb; 16(2):228-37. PubMed ID: 20028710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Utility of the Brief Assessment of Cognitive Health (BACH) computerized screening tool in identifying MS-related cognitive impairment.
    Patrick KS; Chakrabati S; Rhoads T; Busch RM; Floden DP; Galioto R
    Mult Scler Relat Disord; 2024 Feb; 82():105398. PubMed ID: 38183694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparing long-term results of PASAT and SDMT scores in relation to neuropsychological testing in multiple sclerosis.
    Sonder JM; Burggraaff J; Knol DL; Polman CH; Uitdehaag BM
    Mult Scler; 2014 Apr; 20(4):481-8. PubMed ID: 24019305
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Taking the tester out of the SDMT: A proof of concept fully automated approach to assessing processing speed in people with MS.
    Patel VP; Shen L; Rose J; Feinstein A
    Mult Scler; 2019 Oct; 25(11):1506-1513. PubMed ID: 30079822
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stages of brain volume loss and performance in the Brief International Cognitive Assessment for Multiple Sclerosis.
    Miyazaki Y; Niino M; Takahashi E; Nomura T; Naganuma R; Amino I; Akimoto S; Minami N; Kikuchi S
    Mult Scler Relat Disord; 2022 Nov; 67():104183. PubMed ID: 36116381
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Brain volumetric correlates of remotely versus in-person administered symbol digit modalities test in multiple sclerosis.
    Buyukturkoglu K; Dworkin JD; Leiva V; Provenzano FA; Guevara P; De Jager PL; Leavitt VM; Riley CS
    Mult Scler Relat Disord; 2022 Dec; 68():104247. PubMed ID: 36274283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Introducing Multiple Screener: An unsupervised digital screening tool for cognitive deficits in MS.
    van Dongen L; Westerik B; van der Hiele K; Visser LH; Schoonheim MM; Douw L; Twisk JWR; de Jong BA; Geurts JJG; Hulst HE
    Mult Scler Relat Disord; 2020 Feb; 38():101479. PubMed ID: 31760365
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Brain MRI disease burden and sex differences in cognitive performance of patients with multiple sclerosis.
    Motyl J; Friedova L; Ganapathy Subramanian R; Vaneckova M; Fuchs TA; Krasensky J; Blahova Dusankova J; Kubala Havrdova E; Horakova D; Uher T
    Acta Neurol Belg; 2024 Feb; 124(1):109-118. PubMed ID: 37552396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new assessment tool for patients with multiple sclerosis from Spanish-speaking countries: validation of the Brief International Cognitive Assessment for MS (BICAMS) in Argentina.
    Vanotti S; Smerbeck A; Benedict RH; Caceres F
    Clin Neuropsychol; 2016 Oct; 30(7):1023-31. PubMed ID: 27668977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers.
    Fenu G; Fronza M; Lorefice L; Arru M; Coghe G; Frau J; Marrosu MG; Cocco E
    BMC Neurol; 2018 Dec; 18(1):212. PubMed ID: 30567519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Digital symbol-digit modalities test with modified flexible protocols in patients with CNS demyelinating diseases.
    Seo D; So JM; Kim J; Jung H; Jang I; Kim H; Kang DW; Lim YM; Choi J; Lee EJ
    Sci Rep; 2024 Jun; 14(1):14649. PubMed ID: 38918552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in a Colombian Population.
    Alarcón AN; Ayala OD; García JR; Montañés P
    Mult Scler Relat Disord; 2020 Jul; 42():102072. PubMed ID: 32330844
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities Test.
    Parmenter BA; Weinstock-Guttman B; Garg N; Munschauer F; Benedict RH
    Mult Scler; 2007 Jan; 13(1):52-7. PubMed ID: 17294611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validation of the Guy's Neurological Disability Scale as a screening tool for cognitive impairment in multiple sclerosis.
    Akatani R; Chihara N; Tachibana H; Koto S; Kowa H; Kanda F; Matsumoto R; Toda T
    Mult Scler Relat Disord; 2019 Oct; 35():272-275. PubMed ID: 31442905
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Practice effect in Symbol Digit Modalities Test in multiple sclerosis patients treated with natalizumab.
    Roar M; Illes Z; Sejbaek T
    Mult Scler Relat Disord; 2016 Nov; 10():116-122. PubMed ID: 27919477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A new look at an old test: Normative data of the symbol digit modalities test -Oral version.
    Strober LB; Bruce JM; Arnett PA; Alschuler KN; Lebkuecher A; Di Benedetto M; Cozart J; Thelen J; Guty E; Roman C
    Mult Scler Relat Disord; 2020 Aug; 43():102154. PubMed ID: 32450507
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Progressive multiple sclerosis, cognitive function, and quality of life.
    Højsgaard Chow H; Schreiber K; Magyari M; Ammitzbøll C; Börnsen L; Romme Christensen J; Ratzer R; Soelberg Sørensen P; Sellebjerg F
    Brain Behav; 2018 Feb; 8(2):e00875. PubMed ID: 29484253
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Normatization of the symbol digit modalities test-oral version in a Latin American country.
    Vanotti S; Cores EV; Eizaguirre B; Angeles M; Rey R; Villa A; Cáceres F
    Appl Neuropsychol Adult; 2015; 22(1):46-53. PubMed ID: 25529591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.